Vaccinex (VCNX) Short Interest Ratio & Short Volume → Trump Asset Seizure Threat Alert: Could Your Savings Be Next? (From American Hartford Gold Group) (Ad) Free VCNX Stock Alerts $5.51 -0.05 (-0.90%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Vaccinex Short Interest DataCurrent Short Volume13,000 sharesPrevious Short Volume16,200 sharesChange Vs. Previous Month-19.75%Dollar Volume Sold Short$77,220.00Short Interest Ratio / Days to Cover0.9Last Record DateApril 30, 2024Outstanding Shares1,230,000 sharesFloat Size541,600 sharesShort Percent of Float2.40%Today's Trading Volume6,761 sharesAverage Trading Volume6,980 sharesToday's Volume Vs. Average97% Short Selling Vaccinex ? Sign up to receive the latest short interest report for Vaccinex and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVCNX Short Interest Over TimeVCNX Days to Cover Over TimeVCNX Percentage of Float Shorted Over Time Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit Vaccinex Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202413,000 shares $77,220.00 -19.8%2.4%0.9 $5.94 4/15/202416,200 shares $81,486.00 +157.1%3.0%1.2 $5.03 3/31/20246,300 shares $46,683.00 -28.4%1.2%0.5 $7.41 3/15/20248,800 shares $70,840.00 -40.5%1.5%0.8 $8.05 2/29/202414,800 shares $130,240.00 +21.3%2.5%1.4 $8.80 2/15/202412,200 shares $149,450.00 -55.6%3.0%1.2 $12.25 Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 1/31/202427,500 shares $17,201.25 -26.3%0.4%0.3 $0.63 1/15/202437,300 shares $21,596.70 -55.9%0.6%0.4 $0.58 12/31/202384,600 shares $56,242.08 +593.4%1.3%0.2 $0.66 12/15/202312,200 shares $6,679.50 -45.3%0.2%0 $0.55 11/30/202322,300 shares $16,702.70 -55.8%0.4%0 $0.75 11/15/202350,400 shares $45,360.00 +32.3%0.8%0.1 $0.90 10/31/202338,100 shares $36,614.10 -80.8%0.6%0.1 $0.96 10/15/2023198,000 shares $207,900.00 -37.8%3.1%0.3 $1.05 9/30/2023318,400 shares $359,792.00 +2,080.8%5.0%0.6 $1.13 9/15/202314,600 shares $40,274.10 -88.8%0.7%0.5 $2.76 8/31/2023130,400 shares $26,471.20 +11.7%N/A0.9 $0.20 8/15/2023116,700 shares $27,436.17 -36.9%N/A0.6 $0.24 7/31/2023184,900 shares $53,639.49 -44.8%N/A0.9 $0.29 7/15/2023334,900 shares $103,919.47 +204.5%N/A1.7 $0.31 6/30/2023110,000 shares $39,160.00 -49.7%0.5%0.6 $0.36 6/15/2023218,600 shares $96,184.00 +119.7%1.0%1.5 $0.44 5/31/202399,500 shares $40,307.45 -30.5%0.5%0.7 $0.41 5/15/2023143,100 shares $57,240.00 -4.1%0.8%1.4 $0.40 4/30/2023149,200 shares $53,712.00 +16.0%0.6%0.3 $0.36 4/15/2023128,600 shares $55,580.92 -16.7%0.6%0.3 $0.43 3/31/2023154,400 shares $61,682.80 -9.9%0.7%0.3 $0.40 3/15/2023171,400 shares $71,148.14 -34.2%0.7%0.4 $0.42 2/28/2023260,300 shares $128,588.20 -27.0%1.0%0.5 $0.49 2/15/2023356,600 shares $180,083.00 +161.3%1.4%0.7 $0.51 1/31/2023136,500 shares $81,217.50 +27.2%0.7%0.3 $0.60 1/15/2023107,300 shares $68,135.50 -53.1%0.6%1.9 $0.64 12/30/2022229,000 shares $147,590.50 +22.8%1.3%4.1 $0.64 12/15/2022186,500 shares $130,755.15 +50.5%1.0%3.2 $0.70 11/30/2022123,900 shares $61,974.78 -4.6%0.7%1.7 $0.50 11/15/2022129,900 shares $74,043.00 -50.9%0.6%1.8 $0.57 10/31/2022264,300 shares $156,994.20 +35.8%1.1%3.3 $0.59 10/15/2022194,600 shares $104,111.00 +127.3%0.9%1.3 $0.54 9/30/202285,600 shares $42,372.00 -30.2%0.4%0.6 $0.50 9/15/2022122,600 shares $96,976.60 -6.3%0.6%0.9 $0.79The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. VCNX Short Interest - Frequently Asked Questions What is Vaccinex's current short interest? Short interest is the volume of Vaccinex shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 13,000 shares of VCNX short. 2.40% of Vaccinex's shares are currently sold short. Learn More on Vaccinex's current short interest. What is a good short interest ratio for Vaccinex? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VCNX shares currently have a short interest ratio of 1.0. Learn More on Vaccinex's short interest ratio. What is a good short interest percentage for Vaccinex? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.40% of Vaccinex's floating shares are currently sold short. Is Vaccinex's short interest increasing or decreasing? Vaccinex saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 13,000 shares, a drop of 19.8% from the previous total of 16,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vaccinex's float size? Vaccinex currently has issued a total of 1,230,000 shares. Some of Vaccinex's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vaccinex currently has a public float of 541,600 shares. How does Vaccinex's short interest compare to its competitors? 2.40% of Vaccinex's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Vaccinex: eFFECTOR Therapeutics, Inc. (3.12%), Hepion Pharmaceuticals, Inc. (1.19%), Cyclerion Therapeutics, Inc. (0.99%), Pasithea Therapeutics Corp. (1.34%), Bionomics Limited (1.45%), Virios Therapeutics, Inc. (1.24%), Cadrenal Therapeutics, Inc. (0.80%), Processa Pharmaceuticals, Inc. (24.82%), TransCode Therapeutics, Inc. (2.29%), Trevena, Inc. (0.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Vaccinex stock? Short selling VCNX is an investing strategy that aims to generate trading profit from Vaccinex as its price is falling. VCNX shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vaccinex? A short squeeze for Vaccinex occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VCNX, which in turn drives the price of the stock up even further. How often is Vaccinex's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VCNX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: eFFECTOR Therapeutics Short Squeeze Hepion Pharmaceuticals Short Squeeze Cyclerion Therapeutics Short Squeeze Pasithea Therapeutics Short Squeeze Bionomics Short Squeeze Virios Therapeutics Short Squeeze Cadrenal Therapeutics Short Squeeze Processa Pharmaceuticals Short Squeeze TransCode Therapeutics Short Squeeze Trevena Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VCNX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishingis this a buy and hold stock?Tips4TradersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersBiden to Drop BOMBSHELL June 13th?Paradigm Press